Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLowland Inv. Regulatory News (LWI)

Share Price Information for Lowland Inv. (LWI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 125.00
Bid: 124.50
Ask: 125.50
Change: -0.50 (-0.40%)
Spread: 1.00 (0.803%)
Open: 125.00
High: 125.00
Low: 124.50
Prev. Close: 125.50
LWI Live PriceLast checked at -
Lowland Investment Company is an Investment Trust

aims to give shareholders a higher than average return with growth of both capital and income over the medium to long term

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

25 May 2021 13:05

RNS Number : 7680Z
Lowland Investment Co PLC
25 May 2021
 

HENDERSON INVESTMENT FUNDS LIMITED

 

LOWLAND INVESTMENT COMPANY PLC

 

Legal Entity Identifier: 2138008RHG5363FEHV19

 

25 May 2021

 

LOWLAND INVESTMENT COMPANY PLC

Unaudited results for the half-year ended 31 March 2021

 

 

This announcement contains regulated information.

 

Investment objective

The Company aims to give shareholders a higher than average return with growth of both capital and income over the medium to long-term, by investing in a broad spread of predominantly UK companies. The Company measures its performance against the FTSE All-Share Index Total Return.

 

Investment policy

Asset Allocation

 

The Company will invest in a combination of large, medium and smaller companies listed in the UK. We are not constrained by the weightings of any index; we focus instead on controlling absolute risk by diversifying on the basis of underlying company characteristics such as size, industry, economic sensitivity, clients and management. In normal circumstances up to half the portfolio will be invested in FTSE 100 companies; the remainder will be divided between small- and medium-sized companies. On occasions the Manager will buy shares listed overseas. The Manager may also invest a maximum of 15% in other listed trusts.

 

Dividend

 

The Company aims to provide shareholders with better-than-average dividend growth.

 

Gearing

 

The Board believes that debt in a closed-end fund is a valuable source of long-term outperformance, and therefore the Company will usually be geared. At the point of drawing down debt, gearing will never exceed 29.99% of the portfolio valuation. Borrowing will be a mixture of short and long-dated debt, depending on relative attractiveness of rates.

 

Key data for the six months to 31 March 2021

Net Asset Value ('NAV') Total Return

33.0%

Benchmark1 Total Return

18.5%

Growth in dividend

0%

Dividend in respect of the period

30.0p

 

1 FTSE All-Share Index

 

Financial highlights

 

 

Half-Year Ended

31 Mar 2021

Half-Year Ended

31 Mar 2020

Year Ended

30 Sept 2020

NAV per ordinary share1

1,350p

985p

1,031p

Share price2

1,235p

900p

914p

Market capitalisation

£334m

£243m

£247m

Dividend per share

30.0p

30.0p

60.0p

Ongoing charge including performance fee3

 n/a

0.7%

0.7%

Ongoing charge excluding performance fee3

0.6%

0.7%

0.7%

Dividend yield4

4.9%

6.7%

6.6%

Gearing

13.0%

17.2%

15.0%

Discount

8.5%

8.6%

9.2%

 

1 NAV with debt at par value

2 Using mid-market closing price

3 With effect from 1 October 2020 the performance fee has been removed

4 Based on dividends paid and declared in respect of the previous twelve month period

 

Total return performance (including dividends reinvested and excluding transaction costs)

 

 

6 months

%

1 year

%

3 years

%

5 years

%

10 years

%

Net Asset Value

33.0

47.2

-1.3

22.0

111.2

Share Price1

39.1

45.9

-4.1

18.1

114.8

Benchmark2

18.5

26.7

9.9

35.7

79.0

 

1 Using mid-market closing price

2 FTSE All-Share Index

 

Sources: Morningstar Direct, Funddata, Refinitiv Datastream and Janus Henderson

 

 

Historical record - Year to 30 September

 

 

 

 

2011

 

 

2012

 

 

2013

 

 

2014

 

 

2015

 

 

2016

 

 

2017

 

 

2018

 

 

2019

 

 

2020

As at

31 Mar 20211

Net assets2 (£m)

214

266

347

362

355

387

440

439

386

 279

365

Per ordinary share

NAV3

811p

1,008p

1,307p

1,346p

1,318p

1,432p

1,628p

1,625p

1,428p

1031p

1,350p

Share price

763p

992p

1,325p

1,355p

1,287p

1,337p

1,504p

1,515p

1,280p

914p

1,235p

Net revenue

28.8p

31.1p

36.7p

39.4p

46.4p

47.7p

49.1p

58.6p

68.0p

33.8p

12.8p

Net dividends paid

28.0p

30.5p

34.0p

37.0p

41.0p

45.0p

49.0p

54.0p

59.5p

60.0p

30.0p4

 

1 Net revenue and net dividends paid are for the six month period ended 31 March 2021

2 Attributable to ordinary shares

3 NAV with debt at par value

4 First interim dividend of 15.0p per ordinary share paid on 30 April 2021 and second interim dividend of 15.0p per ordinary share that will be paid on 30 July 2021

 

 

INTERIM MANAGEMENT REPORT

 

 

CHAIRMAN'S STATEMENT

 

Overview

 

It is a pleasure to report that, after a period of disappointing performance, the portfolio bounced back in the first half of the year, with NAV increasing by 33.0% against the benchmark's 18.5%. The previous financial year had started hopefully, only for those hopes to be dashed in March 2020 by the effects of the pandemic. The portfolio's focus on the UK, particularly the industrial and financial sectors, and its value bias, were particularly punished by the pandemic. It is these same characteristics which have led our recovery, as the likely benefits of the roll-out of vaccines became apparent. This trend has continued since the end of March, the NAV having increased by 7.9% compared to the benchmark's 5.1%.

 

Dividends

 

The timing of the pandemic was such that its full effect on the pattern of our dividend income was not felt in the six months ended 31 March 2020, in which earnings per share declined to 14.5p from 22.2p in the previous comparable period. The 12.8p recorded in the first half of 2021 therefore masks a recovery in the underlying pattern of dividend income, which the Fund Managers anticipate continuing, although not uniformly across all sectors. We expect income to be higher this year than last, and that the extent of recovery next year will depend on the vigour of the recovery of the domestic economy. Against this background the Board has today declared a second unchanged dividend of 15p, making 30p for the year to date. We will keep a weather eye on the prospects of a full and timeous recovery of income, and judge accordingly on whether we can prudently continue to stand by our progressive dividend policy.

 

Gearing

 

Net debt increased from £42.6mn at year end to £46.1mn at the end of March, but the rise in asset values resulted in gearing reducing in percentage terms from 15.0% to 13.0%. Since the end of March net investment has resulted in gearing moving to £55.6m or 14.3%.

 

Share price discount

 

The discount on the Company's share price reduced marginally from 9.2% at financial year end to 8.5% as at 31st March and most recently 4.2%.

 

The Board

 

We recently announced that Helena Vinnicombe was appointed as a non-executive Director with effect from 1 May. We are delighted to welcome Helena to the Board, bringing as she does, deep experience of all aspects of investment management, in which industry she spent her executive career.

 

Outlook

 

Central bankers are convinced that the rise in inflation we are seeing is a transitory phenomenon and that expectations remain well anchored at lower levels. Our managers will remain alert to any complacency, since a sustained rise in inflation would lead to rising interest rates, which could undermine equity valuations. It is also possible that central bankers will resist upward pressure in rates and intervene to cap rates, which would accelerate an already dramatic recovery

 

Our fortunes are more tied to the performance of the domestic economy than many of our peers, particularly as over half the portfolio is in small- and medium-sized companies. This domestic exposure has been a headwind to performance in recent years given the prolonged uncertainty caused by Brexit, the lack of consumer confidence, and latterly the pandemic. There are signs that these headwinds have largely reversed. The UK Government, having initially struggled more than most with the effects of the pandemic, seems to have done better than most in rolling out a comprehensive vaccination programme. There is scope for a marked recovery in the UK economy. The UK market as a whole looks undervalued compared with most other markets, and does not appear to have priced in the recovery in profitability which seems likely. Against this background, the Fund Managers are continuing to find good value across much of the UK equity market, particularly in areas that are most set to benefit from the re-opening of the economy.

 

 

 

Robert Robertson

Chairman

25 May 2021

 

 

 

Equity allocation as at 31 March 2021

 

Sector Weightings

% as at 31 March 2021

 

Company

Benchmark1

Basic Materials

4.9

9.4

Consumer Discretionary

12.0

12.9

Consumer Staples

1.1

15.5

Energy

5.1

7.6

Financials

33.5

23.4

Health Care

4.5

8.4

Industrials

25.3

12.7

Real Estate

4.7

3.0

Technology

2.0

1.8

Telecommunications

2.7

2.3

Utilities

4.2

3.0

Total

100.0

100.0

 

 

Equity allocation as at 30 September 2020

 

 

Sector Weightings

% as at 30 September 2020

 

Company

Benchmark1

Basic Materials

6.5

8.8

Consumer Goods

2.7

11.8

Consumer Services

11.2

12.6

Financials

35.0

24.9

Health Care

6.5

11.4

Industrials

23.5

13.1

Oil & Gas

5.3

6.6

Technology

0.8

1.2

Telecommunications

1.3

2.1

Tobacco

-

4.1

Utilities

7.2

3.4

Total

100.0

100.0

 

The inclusion of a separate table in this announcement for the year end comparison reflects the change of sectors seen between the 2020 and 2021 financial years, and the relevant data for a fuller comparison being unavailable.

 

 

Market Cap Weightings (%)

 

 

As at 31 Mar 2020

 

Company

Benchmark1

FTSE 100

43.6

78.7

FTSE 250

18.5

17.9

FTSE Small-Cap

14.6

3.4

FTSE AIM

16.5

-

FTSE Fledgling

1.6

-

Overseas

3.5

-

Other

1.7

-

Total

100.0

100.0

 

1 FTSE All-Share Index

 

 

 

FUND MANAGERS' STATEMENT

 

Performance Review

 

The six months to the end of March saw a strong recovery in the portfolio reflecting the reaction to the successful development of several COVID-19 vaccines. During this period the net asset value grew 33.0%, while the FTSE All-Share rose 18.5% (both figures on a total return basis). The recovery was broadly led by the same stocks and sectors that had underperformed at the peak of the pandemic. Specifically, the comparatively large weighting in Industrials and Financials provided the main active contribution to relative performance, having been the largest detractor during the previous financial year. The underweight position in Consumer Staples also aided relative performance.

 

Within the Industrials sector performance was predominantly driven by stock selection, with the sector as a whole performing approximately in line with the UK market. This was a reversal of what happened in the first half of FY20, as a number of the Company's holdings exposed to civil aerospace (such as Senior and Rolls-Royce), recovered strongly. Within Financials, performance was driven fairly equally by stock selection and allocation to the sector. The sector outperformed as bank dividends were allowed to resume by the regulator. Balance sheets remained broadly well capitalised and a rise in bond yields from very low levels should benefit earnings in future years. Within the portfolio, insurer Aviva performed strongly as it continued to make good progress on disposals under a new Chief Executive. International Personal Finance was also a strong contributor following refinancing a bond ahead of its maturity in early 2021.

 

In terms of absolute performance, the top contributors are shown in the table below.

 

 

Share price total return (%)

Contribution to return (%)

Ilika

119.7

1.6

K3 Capital

104.5

1.3

Royal Dutch Shell

47.4

1.2

Henderson Opportunities Trust

58.7

1.0

Prudential

39.6

1.0

Examining each in turn:

 

1. Ilika continued to make steady progress towards commercialisation of their solid state batteries.

2. K3 Capital successfully integrated two acquisitions funded via an equity placing last year (in which the Company participated).

3. Royal Dutch Shell benefitted from a rise in the oil price and a return to modest dividend growth following the rebasing last year.

4. Henderson Opportunities Trust ('HOT') performed well in net asset value terms and its discount to net asset value narrowed. The position was modestly reduced following strong performance but continues to be held within the portfolio, as it brings early stage company exposure while paying a growing dividend. Note the position in HOT is excluded when calculating the Company's management fee since it is also managed by Janus Henderson Investors.

5. Prudential performed well as it approaches the spin-out of its US business, which should allow investors to focus on the faster growing Asian business.

The top five detractors to absolute returns were:

 

 

Share price total return (%)

Contribution to return (%)

GlaxoSmithKline

-8.6

-0.4

4D Pharma

-30.9

-0.4

SIMEC Atlantis Energy

-65.6

-0.3

Pennon Group

-15.0

-0.2

XP Power

-9.5

-0.1

 

Examining each in turn:

 

1. GlaxoSmithKline reported disappointing 2021 guidance, as one of its key products (a shingles vaccine) continues to see sales materially impacted by COVID-19.

2. 4D Pharma, an early stage drug development company, agreed a merger with a special purpose acquisition company in order to further fund their research & development spend. The progress towards commercialising their pipeline of predominantly oncology products remains slower than originally anticipated.

3. SIMEC Atlantis Energy is aiming to convert a coal fired power plant in Wales to one that uses waste pellets (for example of non-recyclable plastics). This is an ambitious project that involves the drawing together of planning permissions, environmental permits, financing and offtake agreements. As a result of this complexity the timeline for reaching full commercialisation has been pushed back. The position is very small.

4. Pennon Group had outperformed during the previous financial year following the sale of its waste management business. In the current financial year it lagged a rising market as a result of its more defensive exposure. The position was sold in the first quarter of this calendar year as it reached what we saw as a fair valuation.

5. XP Power fell modestly having performed well since the position was purchased in early 2019. The position was sold in the fourth quarter of calendar 2020.

 

Income review

 

Earnings per share were 12.8p during the first half, compared to 22.2p and 14.5p in the first half of 2019 and 2020 respectively. Earnings per share were down in the first half of the year relative to 2020 levels as the first approximately four months of the previous financial year were not impacted by the pandemic. We are expecting investment income for the full year to rise meaningfully as there are timing differences, with a number of the resumed final dividends becoming ex dividend in April (shortly after the Company's half year end).

 

The majority of companies that suspended their dividends in FY20, with the exception of the most affected areas such as leisure, physical retail and civil aerospace, have resumed dividend payments. This resumption has been most recent in the banks, following the announcement from the PRA in December that dividends were allowed to resume.

 

The magnitude of further dividend growth from these levels will be dependent on the shape of the earnings recovery. Given the Company's exposure to small- and medium-sized companies that are, on average, more domestically focused than larger companies, for this portfolio the determining factor in dividend growth will be the speed of the domestic recovery.

 

As we are still at a relatively early stage in the economic recovery, with a large amount of unknowns (such as whether consumers will choose to spend the excess savings built up over the past year), it remains difficult to forecast future investment income with any degree of precision. We do, however, expect further growth in income from these levels as the worst affected sectors are able to re-open, and sectors such as banks return to more normalised dividend pay-out ratios.

 

Activity

 

During the period the exposure to companies that will benefit from the economy recovering was increased. The pick-up in activity could result in an increase in inflation over time as companies gain some pricing power. The evidence for inflation becoming a growing concern has been the recent weakness in the Gilt market. An increase in long term interest rates should help Banks with their lending margins. The positions in Barclays, Lloyds, HSBC and Natwest were increased as a result, while Pennon (a water utility) was sold as the valuation looked demanding given the rise in long term interest rates.

 

The position in RSA was increased early in the period because the valuation metrics suggested it was cheap even though there was no obvious short-term catalyst to inspire confidence on the trading front. However, because of the long-term value it offered it received an agreed offer from an insurance consortium at around a 40% premium to its undisturbed price. We subsequently sold the holding and some of the proceeds were used to buy M&G shares. It may become an increasing theme, if stock market investors do not look through short term issues and long-term value is evident, more companies will receive bid approaches from other companies in their industry.

 

On valuation grounds we sold the holding in Croda and started to build up one in Vertu, a motor vehicle distributor. The company has a highly respected management and should benefit from the economic recovery.

 

Environmental, social and governance (ESG) considerations

 

The core principles that are at the root of a sound approach to ESG matters have always formed an implicit part of Lowland's investment process. With the subject growing in prominence we are seeking to improve disclosure with shareholders, with further details to come in the annual report. These issues are important not only as a standalone objective (in order to allocate the capital of the Company to companies with the most responsible and sustainable practices), but it is also crucial for us as fund managers to identify the key opportunities and risks for any companies either held in or under consideration for the portfolio.

 

Our approach does not extend to the exclusion of specific sectors (such as fossil fuels). Some fossil fuel companies held (such as BP and Royal Dutch Shell) will form a necessary part of the energy transition and are spending material sums shifting their portfolios towards renewable energy. It continues to be our view that engagement is more conducive to change than exclusion.

 

Outlook

 

The economy is opening up, with consumer demand returning along with corporate capital spend projects that had been on hold now being actioned. This is happening after a period in which companies have been reducing their cost base and refocusing their business as a response to the uncertainties around the pandemic. The pick- up in sales on the reduced cost base will lead to an improvement in operating margins. The estimates investors have for many stocks may prove to be too low. It is better than expected earnings that is driving share prices upwards. Prices have made a good recovery from the levels to which they fell at the end of the first quarter last year. However, the portfolio remains reasonably geared as we do not believe that the market is fully pricing in the likely economic recovery and the much improved outlook for profits.

 

 

James Henderson and Laura Foll

Fund Managers

25 May 2021

 

 

Related party transactions

 

The Company’s current related parties are its Directors and Janus Henderson. There have been no material transactions between the Company and its Directors during the year and the only amounts paid to them were in respect of Directors’ remuneration and expenses incurred on the Company’s business, for which there were no outstanding amounts payable at the period end.

 

In relation to the provision of services by Janus Henderson, other than fees payable by the Company in the ordinary course of business and the provision of sales and marketing services, there have been no material transactions with Janus Henderson affecting the financial position of the Company during the year under review.

 

Principal risks and uncertainties

 

The principal risks and uncertainties associated with the Company’s business can be divided into various areas:

 

Global pandemic;

Investment activity and strategy;

Portfolio and market price;

Dividend income;

Financial;

Gearing;

Tax and regulatory; and

Operational.

 

Information on these risks and how they are managed is given in the Annual Report for the year ended 30 September 2020. In the view of the Board, these principal risks and uncertainties are as applicable to the remaining six months of the financial year as they were to the six months under review.

 

 

Statement of Directors' Responsibilities

 

The Directors confirm that, to the best of their knowledge:

 

(a) the set of financial statements for the half-year to 31 March 2021 has been prepared in accordance with “FRS 104 Interim Financial Reporting”;

 

(b) the Interim Management Report includes a fair review of the information required by Disclosure Guidance and Transparency Rule 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year); and

 

(c) the Interim Management Report includes a fair review of the information required by the Disclosure Guidance and Transparency Rule 4.2.8R (disclosure of related party transactions and changes therein).

 

 

 

On behalf of the Board

Robert Robertson

Chairman

25 May 2021

 

 

INVESTMENT PORTFOLIO

 

As at 31 March 2021

 

 

Company

 

 

Sector

 

Market value

£'000

 

% of

portfolio

Phoenix

Life Insurance

12,278

 3.0

GlaxoSmithKline

Pharmaceuticals and Biotechnology

10,368

 2.5

Prudential

Life Insurance

10,013

 2.4

Royal Dutch Shell

Oil and Gas

9,641

 2.3

Severn Trent

Gas Water and Multi-utilities

8,648

 2.1

Ilika ¹

Electronic and Electrical Equipment

8,417

 2.0

HSBC

Banks

8,168

 2.0

Aviva

Life Insurance

8,164

 2.0

Morgan Advanced Materials

Electronic and Electrical Equipment

7,398

 1.8

Relx

Media

7,276

 1.8

10 Largest

 

90,371

 21.9

BP

Oil and Gas

7,219

 1.8

K3 Capital ¹

Investment Banking and Brokerage Services

7,063

 1.7

National Grid

Gas Water and Multi-utilities

7,056

 1.7

M&G

Investment Banking and Brokerage Services

7,052

 1.7

Irish Continental (Ireland)

Industrial Transportation

6,998

 1.7

Rio Tinto

Industrial Metals and Mining

6,938

 1.7

Vodafone

Telecommunications Service Providers

6,882

 1.7

Standard Chartered

Banks

6,637

 1.6

Direct Line

Non-life Insurance

6,579

 1.6

Barclays

Banks

6,321

 1.5

20 Largest

 

159,116

 38.6

Standard Life Aberdeen

Investment Banking and Brokerage Services

6,062

1.5

Anglo American

Industrial Metals and Mining

5,969

 1.5

Hiscox

Non-life Insurance

5,950

 1.4

Somero Enterprises ¹ (USA)

Industrial Engineering

5,812

 1.4

Redde Northgate

Industrial Transportation

5,711

 1.4

Natwest

Banks

5,691

 1.4

Lloyds Banking

Banks

5,636

 1.4

Mondi

General Industrials

5,550

 1.3

Henderson Opportunities Trust

Closed End Investments - Investment Trust focusing primarily on UK smaller companies

5,460

 1.3

Epwin ¹

Construction and Materials

5,349

 1.3

30 Largest

 

216,306

 52.5

Halfords

Retailers

5,320

 1.3

Headlam

Household Goods and Home Construction

5,097

 1.2

IP Group

Investment Banking and Brokerage Services

4,969

 1.2

Land Securities

Real Estate Investment Trusts

4,831

 1.2

TT Electronics

Technology Hardware and Equipment

4,804

 1.2

DS Smith

General Industrials

4,744

 1.2

Senior

Aerospace and Defence

4,652

 1.1

Randall & Quilter ¹

Non-life Insurance

4,634

 1.1

BAE Systems

Aerospace and Defence

4,545

 1.1

Clarkson

Industrial Transportation

4,437

 1.1

40 Largest

 

264,339

 64.2

FBD (Ireland)

Non-life Insurance

4,434

1.1

Numis ¹

Investment Banking and Brokerage Services

4,430

1.1

IMI

Electronic and Electrical Equipment

4,383

1.0

Hill & Smith

Industrial Metals and Mining

4,300

1.0

Hipgnosis

Closed End Investments - Investment Trust investing in song back catalogues.

4,292

1.0

BT Group

Telecommunications Service Providers

4,180

1.0

Balfour Beatty

Construction and Materials

4,154

1.0

Marks & Spencer

Retailers

3,997

1.0

Studio Retail

Retailers

3,978

1.0

Castings

Industrial Engineering

3,954

1.0

 

 

Company

 

Sector

Market value

£'000

% of

portfolio

50 Largest

 

306,441

 74.4

Bellway

Household Goods and Home Construction

3,914

 0.9

Tesco

Personal Care, Drug and Grocery Stores

3,794

 0.9

AstraZeneca

Pharmaceuticals and Biotechnology

3,732

 0.9

STV

Media

3,663

 0.9

St Modwen Properties

Real Estate Investment and Services

3,610

 0.9

Anexo ¹

Industrial Support Services

3,380

 0.8

International Personal Finance

Finance and Credit Services

3,316

 0.8

Eleco ¹

Software and Computer Services

3,311

 0.8

Hammerson

Real Estate Investment Trusts

3,233

 0.8

Palace Capital

Real Estate Investment Trusts

3,195

 0.8

60 Largest

 

341,589

 82.9

Tyman

Construction and Materials

3,166

 0.8

Ten Entertainment

Travel and Leisure

3,061

 0.7

Chesnara

Life Insurance

3,013

 0.7

H&T Group ¹

Finance and Credit Services

2,940

 0.7

Vitec

Industrial Engineering

2,931

 0.7

Elementis

Chemicals

2,761

 0.7

Churchill China ¹

Household Goods and Home Construction

2,706

 0.7

Helical

Real Estate Investment and Services

2,688

 0.7

Euromoney

Industrial Support Services

2,624

 0.6

Johnson Service ¹

Industrial Support Services

2,550

 0.6

70 Largest

 

370,029

 89.8

Rolls-Royce

Aerospace and Defence

2,510

 0.6

Ibstock

Construction and Materials

2,484

 0.6

Vertu Motors ¹

Retailers

2,430

 0.6

Convatec

Medical Equipment and Services

2,353

 0.6

Daily Mail & General Trust

Media

2,312

 0.6

Ricardo

Construction and Materials

2,234

 0.5

Reach

Media

2,155

 0.5

Renold ¹

Industrial Engineering

2,145

 0.5

Provident Financial

Finance and Credit Services

2,028

 0.5

Secure Income REIT ¹

Real Estate Investment Trusts

1,977

 0.5

80 Largest

 

392,657

 95.3

Oxford Sciences Innovation ²

Pharmaceuticals and Biotechnology

1,920

 0.5

Alpha Financial Markets ¹

Industrial Support Services

1,890

 0.5

Shoe Zone ¹

Retailers

1,496

 0.4

Centrica

Gas Water and Multi-utilities

1,489

 0.4

Appreciate ¹

Finance and Credit Services

1,473

 0.3

Sabre Insurance

Non-life Insurance

1,324

 0.3

Airea ¹

Household Goods and Home Construction

1,238

 0.3

Carclo

General Industrials

1,067

 0.3

Jadestone Energy ¹

Oil and Gas

1,018

 0.2

Indus Gas ¹

Oil and Gas

981

 0.2

90 Largest

 

406,553

 98.7

Finsbury Food Group ¹

Food Producers

847

 0.2

Esken

Industrial Transportation

804

 0.2

Wadworth - Ordinary shares ²

Travel and Leisure

743

 0.2

Velocys ¹

Alternative Energy

594

 0.1

Serica Energy ¹

Oil and Gas

563

 0.1

SIMEC Atlantis Energy ¹

Alternative Energy

397

 0.1

Severfield

Construction and Materials

350

 0.1

Faron Pharmaceuticals ¹ (Finland)

Pharmaceuticals and Biotechnology

335

 0.1

Premier Oil

Oil and Gas

280

 0.1

Wadworth - Preference shares ²

Travel and Leisure

126

 -

100 Largest

 

411,592

 99.9

 

1 AIM Stocks

2 Unlisted Investments

Source: Janus Henderson 

CONDENSED INCOME STATEMENT

 

 

(Unaudited)

Half-year ended

31 March 2021

(Unaudited)

Half-year ended

31 March 2020

(Audited)

Year ended

30 September 2020

 

Revenue

return

£'000

Capital

return

£'000

 

Total

£'000

Revenue

return

£'000

Capital

return

£'000

 

Total

£'000

Revenue

return

£'000

Capital

return

£'000

 

Total

£'000

 

 

 

 

 

 

 

 

 

 

Gains/(losses) on investments held at fair value through profit or loss

-

91,266

91,266

-

(114,880)

(114,880)

-

(98,742)

(98,742)

 

 

 

 

 

 

 

 

 

 

Income from investments

4,477

-

4,477

4,913

-

4,913

11,124

-

11,124

 

 

 

 

 

 

 

 

 

 

Other interest receivable and similar income

57

-

57

81

-

81

128

-

128

 

---------

--------

---------

---------

--------

---------

---------

---------

---------

 

 

 

 

 

 

 

 

 

 

Gross revenue and capital gains/(losses)

4,534

91,266

95,800

4,994

(114,880)

(109,886)

11,252

(98,742)

(87,490)

 

 

 

 

 

 

 

 

 

 

Management fee and performance fee (note 2)

(409)

(409)

(818)

(433)

(432)

(865)

(835)

(836)

(1,671)

 

 

 

 

 

 

 

 

 

 

Other administrative

expenses (note 2)

(378)

-

(378)

(259)

-

(259)

(547)

-

(547)

 

---------

--------

---------

---------

--------

---------

---------

---------

---------

 

 

 

 

 

 

 

 

 

 

Net return/(loss) before finance costs and taxation

3,747

90,857

94,604

4,302

(115,312)

(111,010)

9,870

 (99,578)

 (89,708)

 

 

 

 

 

 

 

 

 

 

Finance costs

(275)

(275)

(550)

(315)

(315)

(630)

(594)

(593)

(1,187)

 

---------

--------

---------

---------

---------

---------

---------

---------

---------

 

 

 

 

 

 

 

 

 

 

Net return/(loss) before taxation

3,472

90,582

94,054

3,987

(115,627)

(111,640)

9,276

 (100,171)

(90,895)

 

 

 

 

 

 

 

 

 

 

Taxation on net return

(17)

-

(17)

(75)

-

(75)

(144)

-

(144)

 

---------

--------

---------

---------

---------

---------

---------

---------

---------

 

 

 

 

 

 

 

 

 

 

Net return/(loss) after taxation

3,455

90,582

94,037

3,912

(115,627)

(111,715)

9,132

(100,171)

 (91,039)

 

======

======

======

======

=======

======

=====

=======

======

 

 

 

 

 

 

 

 

 

 

Return/(loss) per ordinary

share - basic and diluted

(note 3)

12.8p

335.3p

348.1p

14.5p

(428.0p)

(413.5p)

33.8p

(370.7p)

(336.9p)

 

======

======

======

======

======

======

=====

======

======

 

The total columns of this statement represent the Income Statement of the Company, prepared in accordance with FRS 104. The revenue and capital columns are supplementary to this and are published under guidance from the Association of Investment Companies.

 

The Company has no recognised gains or losses other than those disclosed in the Income Statement and Statement of Changes in Equity.

 

All items in the above statement derive from continuing operations. No operations were acquired or discontinued during the period.

 

The accompanying notes are an integral part of the condensed financial statements.

CONDENSED STATEMENT OF CHANGES IN EQUITY

 

 

(Unaudited)

Half-year ended 31 March 2021

 

Called up share capital

£'000

Share premium account

£'000

Capital redemption

reserve

£'000

Other capital reserves

£'000

 

Revenue

reserve

£'000

 

 

Total

£'000

 

 

 

 

 

 

 

At 1 October 2020

6,755

61,619

1,007

197,968

11,304

278,653

Net return after taxation

-

-

-

90,582

3,455

94,037

Third interim dividend (15.0p) for

the year ended 30 September 2020

 

-

 

-

 

-

 

-

 

(4,053)

 

(4,053)

Final dividend (15.0p) for

the year ended 30 September 2020

 

-

 

-

 

-

 

-

 

(4,053)

 

(4,053)

 

Refund of unclaimed distributions

 

-

 

-

 

-

 

-

 

30

 

30

 

------------

------------

-----------

-----------

-----------

-----------

At 31 March 2021

6,755

61,619

1,007

288,550

6,683

364,614

 

=======

=======

=======

======

=======

=======

 

 

(Unaudited)

Half-year ended 31 March 2020

 

 

Called up share capital

£'000

Share premium account

£'000

Capital redemption

reserve

£'000

Other capital reserves

£'000

 

Revenue

reserve

£'000

 

 

Total

£'000

 

 

 

 

 

 

 

At 1 October 2019

6,755

61,619

1,007

298,139

18,384

385,904

Net (loss)/return after taxation

-

-

-

(115,627)

3,912

(111,715)

Third interim dividend (15.0p) for

the year ended 30 September 2019

 

-

 

-

 

-

 

-

 

(4,053)

 

(4,053)

Final dividend (15.0p) for

the year ended 30 September 2019

 

-

 

-

 

-

 

-

 

(4,053)

 

(4,053)

 

------------

------------

-----------

-----------

-----------

-----------

At 31 March 2020

6,755

61,619

1,007

182,512

14,190

266,083

 

=======

=======

=======

======

=======

=======

 

(Audited)

Year ended 30 September 2020

 

 

Called up share capital

£'000

Share

premium

account

£'000

Capital

redemption

reserve

£'000

Other capital reserves

£'000

Revenue reserve

£'000

Total

£'000

 

 

 

 

 

 

 

At 1 October 2019

6,755

61,619

1,007

298,139

18,384

385,904

Net (loss)/return after taxation

-

-

-

(100,171)

9,132

(91,039)

Third interim dividend (15.0p) for

the year ended 30 September 2019

 

-

 

-

 

-

 

-

 

(4,053)

 

(4,053)

Final dividend (15.0p) for

the year ended 30 September 2019

 

-

 

-

 

-

 

-

 

(4,053)

 

(4,053)

First interim dividend (15.0p) for the

year ended 30 September 2020

 

-

 

-

 

-

 

-

 

(4,053)

 

(4,053)

Second interim dividend (15.0p) for the

year ended 30 September 2020

 

-

 

-

 

-

 

-

 

(4,053)

 

(4,053)

 

-----------

-----------

-----------

-----------

------------

-----------

At 30 September 2020

6,755

61,619

1,007

197,968

11,304

278,653

 

=======

=======

=======

=======

=======

=======

 

 

 

 

 

 

 

____________________

The accompanying notes form an integral part of these condensed financial statements.

 

CONDENSED STATEMENT OF FINANCIAL POSITION

 

 

(Unaudited)

As at

31 March 2021

£'000

(Unaudited)

As at

31 March 2020

£'000

(Audited)

As at

30 September 2020

£'000

Fixed assets

 

 

 

Investments held at fair value through profit or loss (note 4)

411,873

311,793

320,550

 

-----------

-----------

-----------

Current assets

 

 

 

Debtors

1,931

4,039

2,424

Cash at bank

3,468

1,137

3,232

 

-----------

-----------

-----------

 

5,399

5,176

5,656

 

 

 

 

Creditors: amounts falling due within one year

 

(22,872)

 

(21,112)

 

(17,772)

 

-----------

-----------

-----------

Net current liabilities

(17,473)

(15,936)

(12,116)

 

-----------

-----------

-----------

Total assets less current liabilities

394,400

295,857

308,434

 

-----------

-----------

-----------

Creditors: amounts falling due after more than one year

(29,786)

(29,774)

(29,781)

 

-----------

-----------

-----------

Net assets

364,614

266,083

278,653

 

======

======

=======

Capital and reserves

 

 

 

Called up share capital

6,755

6,755

6,755

Share premium account

61,619

61,619

61,619

Capital redemption reserve

1,007

1,007

1,007

Other capital reserves

288,550

182,512

197,968

Revenue reserve

6,683

14,190

11,304

 

-----------

-----------

-----------

Total shareholders' funds

364,614

266,083

278,653

 

======

======

=======

Net asset value per ordinary share - basic and diluted (note 7)

1,349.5p

984.8p

1,031.3p

 

=======

=======

=======

 

 

The accompanying notes form an integral part of these condensed financial statements.

 

CONDENSED STATEMENT OF CASH FLOWS

 

 

 

(Unaudited)

Half-year ended

31 March 2021

£'000

 

(Unaudited)

Half-year ended 31 March 2020

£'000

 

(Audited)

Year ended

30 September 2020

£'000

Cash flows from operating activities

 

 

 

Net gain/(loss) before taxation

94,054

(111,640)

(90,895)

Add back: finance costs

550

630

1,187

Add: (gains)/losses on investments held at fair value through profit or loss

 

(91,266)

 

114,880

 

98,742

Withholding tax on dividends deducted at source

(10)

(111)

(177)

(Increase)/decrease in debtors

(1,010)

791

814

Decrease in creditors

(81)

(609)

(784)

 

-----------

-----------

-----------

Net cash inflow from operating activities

2,237

3,941

8,887

 

-----------

-----------

-----------

Cash flows from investing activities

 

 

 

Purchase of investments

(37,124)

(26,205)

(53,045)

Sale of investments

38,771

31,693

67,917

 

-----------

-----------

-----------

Net cash inflow from investing activities

1,647

5,488

14,872

 

 

 

 

Cash flows from financing activities

 

 

 

Equity dividends paid (net of refund of unclaimed distributions and reclaimed distributions)

 

(8,076)

 

(8,106)

 

(16,212)

Net loans drawn down/(repaid)

4,992

(1,554)

(5,109)

Interest paid

(541)

(640)

(1,207)

 

-----------

-----------

-----------

Net cash outflow from financing activities

(3,625)

(10,300)

(22,528)

 

 

 

 

Net increase/(decrease) in cash and cash equivalents

 

259

 

(871)

 

1,231

 

 

 

 

Cash and cash equivalents at start of year

3,232

2,008

2,008

Effect of foreign exchange rates

(23)

-

(7)

 

-----------

-----------

-----------

Cash and cash equivalents at end of year

3,468

1,137

3,232

 

======

======

======

Comprising:

 

 

 

Cash at bank

3,468

1,137

3,232

 

======

======

======

 

The accompanying notes are an integral part of these condensed financial statements. 

 

 

NOTES TO THE FINANCIAL STATEMENTS

The half-year financial statements cover the period from 1 October 2020 to 31 March 2021 and have not been audited or reviewed by the Company's auditors.

 

1.

Accounting policies - basis of preparation

 

The condensed set of financial statements has been prepared in accordance with FRS 104, Interim Financial Reporting, FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland, and the Statement of Recommended Practice for "Financial Statements of Investment Trust Companies and Venture Capital Trusts" which was issued by the Association of Investment Companies in October 2019.

 

The accounting policies applied are consistent with those of the most recent annual financial statements for the year ended 30 September 2020.

 

2.

Expenses

 

Management fees and finance costs are charged 50% to revenue and 50% to capital. All other administrative expenses are charged wholly to revenue. Performance fees were previously charged wholly to capital, but with effect from 1 October 2020 the performance fee was removed. There was no performance fee payable as at 31 March 2020 or 30 September 2020. Expenses which are incidental to the purchase or sale of an investment are included in the cost or deducted from the proceeds of sale of the investment.

 

3.

Return per ordinary share - basic and diluted

 

 

(Unaudited)

Half-year ended

31 March 2021

£'000

(Unaudited)

Half-year ended

31 March 2020

£'000

(Audited)

Year ended

30 September 2020

£'000

 

The return/(loss) per ordinary share is based on the following figures:

 

 

 

 

Net revenue return

3,455

3,912

9,132

 

Net capital return/(loss)

90,582

(115,627)

(100,171)

 

 

----------

----------

----------

 

Net total return/(loss)

94,037

(111,715)

 (91,039)

 

 

======

======

======

 

Weighted average number of ordinary shares in issue for each period

 

 

27,018,565

 

 

27,018,565

 

 

27,018,565

 

 

 

 

 

 

Revenue return per ordinary share

 

12.8p

 

14.5p

 

33.8p

 

Capital return/(loss) per ordinary share

 

335.3p

 

(428.0p)

 

(370.7p)

 

 

----------

----------

----------

 

Total return/(loss) per ordinary share

 

348.1p

 

(413.5p)

 

(336.9p)

 

 

======

======

======

 

 

 

The Company does not have any dilutive securities; therefore, basic and diluted returns per share are the same.

 

 

4.

Fair value of financial assets and liabilities

 

The table below analyses fair value measurements for investments held at fair value through profit or loss. These fair value measurements are categorised into different levels in the fair value hierarchy based on the valuation techniques used and are defined as follows:

 

Level 1: valued using quoted prices in active markets for identical assets

 

Level 2: valued by reference to valuation techniques using observable inputs other than quoted prices included in Level 1

 

Level 3: valued by reference to valuation techniques using inputs that are not based on observable market data

 

 

Investments held at fair value through profit or loss at 31 March 2021 (unaudited)

Level 1

£'000

Level 2

£'000

Level 3

£'000

Total

£'000

 

Investments

409,084

-

2,789

 

411,873

 

 

 

 

 

 

 

Investments held at fair value through profit or loss at

31 March 2020 (unaudited)

Level 1

£'000

Level 2

£'000

Level 3

£'000

Total

£'000

 

Investments

309,385

-

2,408

311,793

 

 

 

 

 

 

 

Investments held at fair value through profit or loss at

30 September 2020 (audited)

Level 1

£'000

Level 2

£'000

Level 3

£'000

Total

£'000

 

Investments

 

318,055

-

2,495

320,550

 

 

 

 

 

A reconciliation of movements within Level 3 is set out below:

 

 

 

2021

 

 

 

£'000

 

Opening balance

 

2,495

 

Disposal proceeds

 

-

 

Transfers in

 

-

 

Total gain/loss included in the Income Statement

 

 

- on investments written off

 

-

 

- on investments held

 

294

 

Closing balance

 

2,789

 

 

 

The valuation techniques used by the Company are explained in the accounting policies note in the Company's Annual Report for the year ended 30 September 2020.

 

The fair value of the senior unsecured loan notes at 31 March 2021 has been estimated to be £33,661,000 (31 March 2020: £36,221,000; 30 September 2020: £36,624,000). The fair value of the senior unsecured loan notes is calculated using a discount rate which reflects the yield on a UK Gilt of similar maturity plus a suitable credit spread.

 

The senior unsecured loan notes are categorised as level 3 in the fair value hierarchy.

5.

Share capital

 

At 31 March 2021 there were 27,018,565, ordinary shares of 25p each in issue (31 March 2020: 27,018,565; 30 September 2020: 27,018,565). During the half-year ended 31 March 2021 no shares were issued or bought back (31 March 2020 and 30 September 2020: no shares were issued or bought back)

6.

Transaction costs

 

Purchase transaction costs for the half-year ended 31 March 2021 were £174,000 (31 March 2020: £135,000; 30 September 2020: £229,000). Sale transaction costs for the half-year ended 31 March 2021 were £15,000 (31 March 2020: £14,000; 30 September 2020: £29,000). These comprise mainly stamp duty and commission.

 

 

7.

 

Net asset value per ordinary share - basic and diluted

 

The net asset value per ordinary share of 1,349.5p (31 March 2020: 984.8p; 30 September 2020: 1,031.3p) is based on the net assets attributable to the ordinary shares of £364,614,000 (31 March 2020: £266,083,000; 30 September 2020: £278,653,000) and on 27,018,565 ordinary shares (31 March 2020 and 30 September 2020: 27,018,565), being the number of ordinary shares in issue at the end of each period.

 

8.

Dividend

 

On 30 April 2021, a first interim dividend of 15.0p (2020: 15.0p) per ordinary share was paid in respect of the year ending 30 September 2021. A second interim dividend of 15.0p per ordinary share has been declared and will be paid on 30 July 2021 to shareholders on the register of members at the close of business on 2 July 2021. The ex-dividend date will be 1 July 2021. Based on the number of shares in issue on 21 May 2021 of 27,018,565, the cost of the dividend will be £4,053,000 (second interim dividend for the year ended 30 September 2020: £4,053,000).

 

9.

Going concern

 

The assets of the Company consist of securities that are readily realisable. The Directors have also considered the impact of COVID-19, including the impact of income and gearing, and believe that the Company has adequate resources to continue in operational existence for at least twelve months from the date of approval of the financial statements. Having assessed these factors and the principal risks, the Board has determined that it is appropriate for the financial statements to be prepared on a going concern basis.

 

10.

Comparative Information

 

The financial information contained in this half-year report does not constitute statutory accounts as defined in section 434 of the Companies Act 2006. The financial information for the half-years ended 31 March 2021 and 31 March 2020 has not been audited nor reviewed by the Company's auditor.

 

The figures and financial information for the year ended 30 September 2020 are extracted from the latest published accounts and do not constitute the statutory accounts for that year. Those accounts have been delivered to the Registrar of Companies and included the report of the independent auditors, which was unqualified and did not include a statement under either section 498(2) or 498(3) of the Companies Act 2006.

 

A glossary of terms and details of alternative performance measures can be found in the Annual Report for the year ended 30 September 2020.

 

11.

Manager

 

Henderson Investment Funds Limited ('HIFL') is appointed to act as the Company's Alternative Investment Fund Manager. HIFL delegates investment management services to Henderson Global Investors Limited. References to Janus Henderson within these results refer to the services provided by both entities.

       

 

12.

General information

 

Company Status

The Company is a UK-domiciled investment trust company. The registered number is 670489.

The London Stock Exchange Daily Official List SEDOL number is 0536806

The ISIN number is GB0005368062.

The London Stock Exchange (TIDM) Code is LWI.  

The Global Intermediary Identification Number (GIIN) is 2KBHLK.99999.SL.826.

The Legal Entity Identifier Number (LEI) is 2138008RHG5363FEHV19

 

Directors

The Directors of the Company are Robert Robertson (Chairman), Gaynor Coley (Audit Committee Chairman), Duncan Budge, Karl Sternberg, Helena Vinnicombe and Thomas Walker.

 

Corporate Secretary

Henderson Secretarial Services Limited, represented by Helena Harvey ACG.

Email: ITSecretariat@janushenderson.com

 

Registered Office

201 Bishopsgate, London EC2M 3AE.

 

Website

Details of the Company's share price and net asset value, together with general information about the Company, monthly factsheets and data, copies of announcements, reports and details of general meetings can be found at www.lowlandinvestment.com.

 

13.

Half-year report

 

The half-year report will shortly be available on the Company's website or in hard copy from the Company's registered office. An abbreviated version of the half-year report, the 'Update', will be posted to shareholders in June 2021. The Update will also be available on the Company's website, and hard copies will be available at the Company's registered office, 201 Bishopsgate, London EC2M 3AE.

 

For further information, please contact:

 

James Henderson / Laura Foll

Fund Managers

Lowland Investment Company plc

Tel: 020 7818 4370 / 020 7818 6364

 

James de Sausmarez

Director and Head of Investment Trusts

Janus Henderson Investors

Tel: 020 7818 3349

 

Laura Thomas

PR Manager

Janus Henderson Investors

Tel: 020 7818 2636

 

 

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DKPBKBBKDNPB
Date   Source Headline
14th Jun 202412:56 pmRNSNet Asset Value(s)
13th Jun 202412:20 pmRNSNet Asset Value(s)
12th Jun 202412:00 pmRNSNet Asset Value(s)
11th Jun 20241:09 pmRNSNet Asset Value(s)
10th Jun 20244:36 pmRNSNet Asset Value(s)
7th Jun 20242:29 pmRNSNet Asset Value(s)
6th Jun 20241:32 pmRNSNet Asset Value(s)
5th Jun 20244:15 pmRNSUpdate for the Half Year Ended 31 March 2024
5th Jun 202412:19 pmRNSNet Asset Value(s)
4th Jun 20241:03 pmRNSNet Asset Value(s)
3rd Jun 20244:29 pmRNSNet Asset Value(s)
31st May 202411:44 amRNSNet Asset Value(s)
30th May 20243:35 pmRNSHalf-year Report
30th May 20243:32 pmRNSDividend Declaration
30th May 202412:12 pmRNSNet Asset Value(s)
29th May 202412:36 pmRNSNet Asset Value(s)
28th May 20242:45 pmRNSNet Asset Value(s)
24th May 202412:35 pmRNSNet Asset Value(s)
23rd May 202411:34 amRNSNet Asset Value(s)
22nd May 202411:59 amRNSNet Asset Value(s)
21st May 20244:35 pmRNSMonthly Factsheet as at 30 April 2024
21st May 202412:12 pmRNSNet Asset Value(s)
20th May 20242:52 pmRNSNet Asset Value(s)
17th May 202412:11 pmRNSNet Asset Value(s)
16th May 20242:21 pmRNSNet Asset Value(s)
15th May 202412:43 pmRNSNet Asset Value(s)
14th May 202411:49 amRNSNet Asset Value(s)
13th May 20242:45 pmRNSNet Asset Value(s)
10th May 20241:25 pmRNSNet Asset Value(s)
9th May 20241:23 pmRNSNet Asset Value(s)
8th May 202412:55 pmRNSNet Asset Value(s)
7th May 20245:01 pmRNSNet Asset Value(s)
3rd May 20244:00 pmRNSQuotedData's Weekly News & Interview
3rd May 202412:19 pmRNSNet Asset Value(s)
2nd May 202412:17 pmRNSNet Asset Value(s)
1st May 20241:00 pmRNSNet Asset Value(s)
30th Apr 20242:06 pmRNSCompliance with Market Abuse Regulation
30th Apr 20241:42 pmRNSNet Asset Value(s)
29th Apr 20244:28 pmRNSNet Asset Value(s)
26th Apr 20241:26 pmRNSNet Asset Value(s)
25th Apr 202412:29 pmRNSNet Asset Value(s)
24th Apr 202412:32 pmRNSNet Asset Value(s)
23rd Apr 20244:39 pmRNSDoc re. Monthly Factsheet as at 31 March 2024
23rd Apr 202411:46 amRNSNet Asset Value(s)
22nd Apr 20243:37 pmRNSNet Asset Value(s)
19th Apr 202412:33 pmRNSNet Asset Value(s)
18th Apr 20241:07 pmRNSNet Asset Value(s)
17th Apr 202412:02 pmRNSNet Asset Value(s)
16th Apr 202412:01 pmRNSNet Asset Value(s)
15th Apr 20243:49 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.